Comparative Pharmacology
Head-to-head clinical analysis: FLUONID versus FLUTEX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FLUONID versus FLUTEX.
FLUONID vs FLUTEX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Fluocinolone acetonide is a corticosteroid that binds to the glucocorticoid receptor, leading to inhibition of phospholipase A2, reduction of prostaglandin and leukotriene synthesis, and suppression of inflammatory mediators.
Flutamide is a nonsteroidal antiandrogen that competitively inhibits the binding of dihydrotestosterone (DHT) to androgen receptors in target tissues, thereby blocking the androgenic effects.
0.05% cream or ointment applied topically to affected area once daily. Not to exceed 30 g per week.
50 mg orally once daily
None Documented
None Documented
3.5 hours; prolonged to 18–24 hours in severe hepatic impairment.
Terminal elimination half-life: 24–36 hours, permitting once-daily dosing in chronic therapy
Renal 70% as unchanged drug, biliary/fecal 30% as metabolites.
Renal: ~70% (50% unchanged, 20% as metabolites); Biliary/fecal: ~30%
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid